0001493152-23-003889.txt : 20230207 0001493152-23-003889.hdr.sgml : 20230207 20230207213011 ACCESSION NUMBER: 0001493152-23-003889 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230125 FILED AS OF DATE: 20230207 DATE AS OF CHANGE: 20230207 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mack Anthony P. CENTRAL INDEX KEY: 0001818483 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-40064 FILM NUMBER: 23596851 MAIL ADDRESS: STREET 1: C/O VIRPAX PHARMACEUTICALS, INC. STREET 2: 1554 PAOLI PIKE #279 CITY: WEST CHESTER STATE: PA ZIP: 19380 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Virpax Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001708331 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 821510982 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1554 PAOLI PIKE #279 CITY: WEST CHESTER STATE: PA ZIP: 19380 BUSINESS PHONE: 484-875-3195 MAIL ADDRESS: STREET 1: 1554 PAOLI PIKE #279 CITY: WEST CHESTER STATE: PA ZIP: 19380 FORMER COMPANY: FORMER CONFORMED NAME: Virpax Pharmaceuticals Inc. DATE OF NAME CHANGE: 20170602 4/A 1 ownership.xml X0306 4/A 2023-01-25 2023-01-27 0 0001708331 Virpax Pharmaceuticals, Inc. VRPX 0001818483 Mack Anthony P. 1055 WESTLAKES DRIVE, SUITE 300 BERWYN, PA 19312 1 1 1 0 Chief Executive Officer Stock Option (right to buy) 0.867 2023-01-25 4 A 0 125000 0 A 2028-01-25 Common Stock 125000 125000 D The option vests in three equal annual installments commencing on January 25, 2024. This amendment on Form 4/A is being filed to amend the Form 4 filed on January 27, 2023, solely to correct inadvertent errors in the exercise price and expiration date of the Stock Option previously reported in Column 2 and Column 6 of Table II, respectively. /s/ Christopher Chipman, attorney-in-fact 2023-02-07